FluosolR Da and Oxygen as an Adjuvant to the Radiotherapeutic Management of Advanced Head/Neck Carcinoma
- 1 January 1988
- journal article
- research article
- Published by Taylor & Francis in Biomaterials, Artificial Cells and Artificial Organs
- Vol. 16 (1-3) , 511-518
- https://doi.org/10.3109/10731198809132606
Abstract
(1988). FluosolR Da and Oxygen as an Adjuvant to the Radiotherapeutic Management of Advanced Head/Neck Carcinoma. Biomaterials, Artificial Cells and Artificial Organs: Vol. 16, No. 1-3, pp. 511-518. doi: 10.3109/10731198809132606Keywords
This publication has 8 references indexed in Scilit:
- A clinical trial of Fluosol DA 20% in advanced squamous cell carcinoma of the head and neckInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Effects of dose and scheduling on growth delay of the Lewis lung carcinoma produced by the perfluorochemical emulsion, Fluosol-DA®International Journal of Radiation Oncology*Biology*Physics, 1986
- Increased radiosensitivity of tumors by perfluorochemicals and carbogenInternational Journal of Radiation Oncology*Biology*Physics, 1985
- Oxygen tension in human tumors: in vivo mapping using CT-guided probes.Radiology, 1985
- Use of a perfluorochemical emulsion to improve oxygenation in a solid tumorInternational Journal of Radiation Oncology*Biology*Physics, 1985
- Perfluorochemical Emulsions Can Increase Tumor RadiosensitivityScience, 1984
- The Preoperative Treatment of Severely Anemic Patients with a Perfluorochemical Oxygen-Transport Fluid, Fluosol-DANew England Journal of Medicine, 1982
- The Histological Structure of Some Human Lung Cancers and the Possible Implications for RadiotherapyBritish Journal of Cancer, 1955